Back

Extracellular RNA moves from the glomerulus to the renal tubule

Hunter, R. W.; Kumar, S.; Coward, R. J.; Buck, A. H.; Dear, J. W.

2021-06-15 molecular biology
10.1101/2021.06.15.448584 bioRxiv
Show abstract

There is a wealth of indirect evidence that extracellular RNA (exRNA) signalling can regulate renal tubular epithelial cell function. However, the physiological importance of this signalling is uncertain. We sought to determine the extent of extracellular RNA transfer between cells in a healthy kidney. We tested the hypothesis that RNA travels from glomerular podocytes to renal tubular epithelial cells. We developed a method to track exRNA in the kidney using SLAMseq (SH-linked alkylation for the metabolic sequencing of RNA in tissue). We crossed podocin-Cre mice with floxed-stop-UPRT mice to express recombinant uracil phosphoribosyl transferase (UPRT) in podocytes. Mice were injected with the modified nucleobase 4-thiouracil, which is incorporated into nascent RNA with high efficiency only in UPRT-expressing cells. We harvested glomeruli or tubular cells, extracted RNA and prepared libraries for SLAMseq, in which sites of mRNA labelling with 4-thiouracil are detected as T>C conversions in 3UTRs. In glomeruli, we detected labelling of known podocyte genes but not of genes known to be restricted to endothelial, renal tubular or white blood cells. Setting a false-discovery rate of 1%, the proportion of genes deemed to be labelled with high confidence was 7.1% (95% confidence interval 6.8 - 7.4%) in 4TU-treated podocyte-UPRT mice, 2.5% (2.3 - 2.7%) in Cre-negative controls and 1.0% (0.9 - 1.1%) in 4TU-naive controls. In tubular cells, we detected a small but statistically significant increase in RNA labelling in podocyte-UPRT mice compared to Cre-negative controls (p = 7.4 x 10-16 in a zero-inflated Poisson regression model). We conclude that RNA is transferred from podocytes to renal tubular epithelial cells in vivo under physiological conditions. Our model provides the opportunity to explore the consequences of this novel signalling pathway in health and kidney disease.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Kidney International
25 papers in training set
Top 0.1%
23.4%
2
Journal of the American Society of Nephrology
52 papers in training set
Top 0.1%
7.1%
3
eLife
5422 papers in training set
Top 12%
6.6%
4
Nature Communications
4913 papers in training set
Top 35%
4.3%
5
Development
440 papers in training set
Top 0.6%
4.1%
6
PLOS Biology
408 papers in training set
Top 2%
4.1%
7
Scientific Reports
3102 papers in training set
Top 33%
3.7%
50% of probability mass above
8
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 22%
3.2%
9
PLOS Genetics
756 papers in training set
Top 6%
2.5%
10
PLOS ONE
4510 papers in training set
Top 46%
2.5%
11
Wellcome Open Research
57 papers in training set
Top 0.5%
2.2%
12
Genes & Development
90 papers in training set
Top 0.3%
1.9%
13
JCI Insight
241 papers in training set
Top 3%
1.8%
14
Genome Medicine
154 papers in training set
Top 4%
1.8%
15
Circulation
66 papers in training set
Top 2%
1.4%
16
Developmental Cell
168 papers in training set
Top 9%
1.4%
17
iScience
1063 papers in training set
Top 19%
1.4%
18
Nucleic Acids Research
1128 papers in training set
Top 14%
1.0%
19
Cell Reports
1338 papers in training set
Top 30%
0.9%
20
Genome Biology
555 papers in training set
Top 6%
0.9%
21
RNA
169 papers in training set
Top 0.4%
0.8%
22
Diabetologia
36 papers in training set
Top 0.8%
0.8%
23
BMC Genomics
328 papers in training set
Top 5%
0.8%
24
Science Translational Medicine
111 papers in training set
Top 6%
0.8%
25
American Journal of Physiology-Renal Physiology
25 papers in training set
Top 0.2%
0.8%
26
The EMBO Journal
267 papers in training set
Top 5%
0.7%
27
Cell Reports Medicine
140 papers in training set
Top 8%
0.7%
28
Science Advances
1098 papers in training set
Top 30%
0.7%
29
Kidney360
22 papers in training set
Top 0.6%
0.7%
30
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 2%
0.5%